NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $825 | -69.0% | 18,644 | -66.0% | 0.01% | -63.6% |
| Q2 2023 | $2,665 | +314.5% | 54,762 | +372.6% | 0.02% | +340.0% |
| Q1 2023 | $643 | -1.7% | 11,588 | -28.8% | 0.01% | -44.4% |
| Q4 2022 | $654 | -100.0% | 16,274 | -75.7% | 0.01% | -76.3% |
| Q3 2022 | $2,937,000 | -37.9% | 67,023 | -49.8% | 0.04% | -34.5% |
| Q2 2022 | $4,733,000 | +24.5% | 133,560 | +42.9% | 0.06% | +20.8% |
| Q1 2022 | $3,803,000 | -44.4% | 93,488 | +27.6% | 0.05% | -32.4% |
| Q4 2021 | $6,844,000 | +17.2% | 73,282 | +39.8% | 0.07% | -10.1% |
| Q3 2021 | $5,842,000 | -34.4% | 52,426 | -33.1% | 0.08% | -19.4% |
| Q2 2021 | $8,903,000 | +70.7% | 78,418 | +52.7% | 0.10% | +28.9% |
| Q1 2021 | $5,216,000 | +21.7% | 51,368 | +19.3% | 0.08% | +81.0% |
| Q4 2020 | $4,285,000 | +17.0% | 43,061 | -15.0% | 0.04% | -42.5% |
| Q3 2020 | $3,661,000 | +281.0% | 50,674 | +73.0% | 0.07% | +114.7% |
| Q3 2019 | $961,000 | +92.2% | 29,292 | +20.9% | 0.03% | -8.1% |
| Q1 2019 | $500,000 | – | 24,238 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |